{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T20:08:15Z","timestamp":1794514095406,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22272091"],"award-info":[{"award-number":["22272091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82061148009"],"award-info":[{"award-number":["82061148009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20732"],"award-info":[{"award-number":["U24A20732"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Nanotechnol."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41565-025-01924-1","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T05:02:25Z","timestamp":1747630945000},"page":"1131-1141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["A collagenase nanogel backpack improves CAR-T cell therapy outcomes in pancreatic cancer"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0281-3172","authenticated-orcid":false,"given":"Zhipeng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1706-6244","authenticated-orcid":false,"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8353-447X","authenticated-orcid":false,"given":"Guoqing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3115-7273","authenticated-orcid":false,"given":"Gongde","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7480-2642","authenticated-orcid":false,"given":"Yuxia","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"1924_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"SL Maude","year":"2018","unstructured":"Maude, S. L. et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N. Engl. J. Med. 378, 439\u2013448 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1924_CR2","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","volume":"377","author":"SS Neelapu","year":"2017","unstructured":"Neelapu, S. S. et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N. Engl. J. Med. 377, 2531\u20132544 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1924_CR3","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","volume":"377","author":"SJ Schuster","year":"2017","unstructured":"Schuster, S. J. et al. Chimeric antigen receptor T cells in refractory B-cell lymphomas. N. Engl. J. Med. 377, 2545\u20132554 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1924_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/j.gastro.2018.03.029","volume":"155","author":"GL Beatty","year":"2018","unstructured":"Beatty, G. L. et al. Activity of mesothelin-specific chimeric antigen receptor T cells against pancreatic carcinoma metastases in a phase 1 trial. Gastroenterology 155, 29\u201332 (2018).","journal-title":"Gastroenterology"},{"key":"1924_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41573-021-00189-2","volume":"20","author":"AJ Hou","year":"2021","unstructured":"Hou, A. J., Chen, L. C. & Chen, Y. Y. Navigating CAR-T cells through the solid-tumour microenvironment. Nat. Rev. Drug Discov. 20, 531\u2013550 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1924_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-med-062315-120245","volume":"68","author":"K Newick","year":"2017","unstructured":"Newick, K., O\u2019Brien, S., Moon, E. & Albelda, S. M. CAR T cell therapy for solid tumors. Annu. Rev. Med. 68, 139\u2013152 (2017).","journal-title":"Annu. Rev. Med."},{"key":"1924_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1158\/2326-6066.CIR-13-0170","volume":"2","author":"GL Beatty","year":"2014","unstructured":"Beatty, G. L. et al. Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce antitumor activity in solid malignancies. Cancer Immunol. Res. 2, 112\u2013120 (2014).","journal-title":"Cancer Immunol. Res."},{"key":"1924_CR8","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.ymthe.2019.07.015","volume":"27","author":"AR Haas","year":"2019","unstructured":"Haas, A. R. et al. Phase I study of lentiviral-transduced chimeric antigen receptor-modified T cells recognizing mesothelin in advanced solid cancers. Mol. Ther. 27, 1919\u20131929 (2019).","journal-title":"Mol. Ther."},{"key":"1924_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2326-6066.CIR-13-0006","volume":"1","author":"MV Maus","year":"2013","unstructured":"Maus, M. V. et al. T cells expressing chimeric antigen receptors can cause anaphylaxis in humans. Cancer Immunol. Res. 1, 26\u201331 (2013).","journal-title":"Cancer Immunol. Res."},{"key":"1924_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth, N., Wicha, M. S. & Zou, W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat. Rev. Immunol. 17, 559\u2013572 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"1924_CR11","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41571-018-0007-1","volume":"15","author":"KC Valkenburg","year":"2018","unstructured":"Valkenburg, K. C., de Groot, A. E. & Pienta, K. J. Targeting the tumour stroma to improve cancer therapy. Nat. Rev. Clin. Oncol. 15, 366\u2013381 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1924_CR12","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41551-021-00737-6","volume":"5","author":"S Lesch","year":"2021","unstructured":"Lesch, S. et al. T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours. Nat. Biomed. Eng. 5, 1246\u20131260 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"1924_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","volume":"21","author":"SM Albelda","year":"2024","unstructured":"Albelda, S. M. CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn. Nat. Rev. Clin. Oncol. 21, 47\u201366 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1924_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho, W. J., Jaffee, E. M. & Zheng, L. The tumour microenvironment in pancreatic cancer\u2014clinical challenges and opportunities. Nat. Rev. Clin. Oncol. 17, 527\u2013540 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1924_CR15","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.cgh.2009.07.039","volume":"7","author":"S Pandol","year":"2009","unstructured":"Pandol, S., Edderkaoui, M., Gukovsky, I., Lugea, A. & Gukovskaya, A. Desmoplasia of pancreatic ductal adenocarcinoma. Clin. Gastroenterol. Hepatol. 7, S44\u2013S47 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1924_CR16","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1073\/pnas.1811067116","volume":"116","author":"J Blando","year":"2019","unstructured":"Blando, J. et al. Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer. Proc. Natl Acad. Sci. USA 116, 1692\u20131697 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1924_CR17","doi-asserted-by":"publisher","first-page":"19609","DOI":"10.1073\/pnas.1908626116","volume":"116","author":"C Tian","year":"2019","unstructured":"Tian, C. et al. Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells. Proc. Natl Acad. Sci. USA 116, 19609\u201319618 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1924_CR18","doi-asserted-by":"publisher","unstructured":"Watt, J. & Kocher, H. M. The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration. OncoImmunology https:\/\/doi.org\/10.4161\/onci.26788 (2014).","DOI":"10.4161\/onci.26788"},{"key":"1924_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","volume":"21","author":"TR Cox","year":"2021","unstructured":"Cox, T. R. The matrix in cancer. Nat. Rev. Cancer 21, 217\u2013238 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"1924_CR20","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1007\/s00018-013-1339-8","volume":"70","author":"E Peranzoni","year":"2013","unstructured":"Peranzoni, E., Rivas-Caicedo, A., Bougherara, H., Salmon, H. & Donnadieu, E. Positive and negative influence of the matrix architecture on antitumor immune surveillance. Cell. Mol. Life Sci. 70, 4431\u20134448 (2013).","journal-title":"Cell. Mol. Life Sci."},{"key":"1924_CR21","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1039\/c5ib00040h","volume":"7","author":"I Acerbi","year":"2015","unstructured":"Acerbi, I. et al. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integr. Biol. 7, 1120\u20131134 (2015).","journal-title":"Integr. Biol."},{"key":"1924_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer 20, 174\u2013186 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1924_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","volume":"25","author":"AD Rhim","year":"2014","unstructured":"Rhim, A. D. et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25, 735\u2013747 (2014).","journal-title":"Cancer Cell"},{"key":"1924_CR24","doi-asserted-by":"publisher","first-page":"28960","DOI":"10.1073\/pnas.2013644117","volume":"117","author":"D Biasci","year":"2020","unstructured":"Biasci, D. et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc. Natl Acad. Sci. USA 117, 28960\u201328970 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1924_CR25","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41591-020-0880-x","volume":"26","author":"B Bockorny","year":"2020","unstructured":"Bockorny, B. et al. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial. Nat. Med. 26, 878\u2013885 (2020).","journal-title":"Nat. Med."},{"key":"1924_CR26","doi-asserted-by":"publisher","first-page":"20212","DOI":"10.1073\/pnas.1320318110","volume":"110","author":"C Feig","year":"2013","unstructured":"Feig, C. et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc. Natl Acad. Sci. USA 110, 20212\u201320217 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1924_CR27","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1053\/j.gastro.2013.07.025","volume":"145","author":"A Ene-Obong","year":"2013","unstructured":"Ene-Obong, A. et al. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. Gastroenterology 145, 1121\u20131132 (2013).","journal-title":"Gastroenterology"},{"key":"1924_CR28","doi-asserted-by":"publisher","unstructured":"Wang, Z. et al. Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attack. Proc. Natl Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.2119463119 (2022).","DOI":"10.1073\/pnas.2119463119"},{"key":"1924_CR29","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1021\/acs.molpharmaceut.8b00319","volume":"15","author":"A Dolor","year":"2018","unstructured":"Dolor, A. & Szoka, F. C. Digesting a path forward: the utility of collagenase tumor treatment for improved drug delivery. Mol. Pharm. 15, 2069\u20132083 (2018).","journal-title":"Mol. Pharm."},{"key":"1924_CR30","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1021\/acsnano.9b02395","volume":"13","author":"A Zinger","year":"2019","unstructured":"Zinger, A. et al. Collagenase nanoparticles enhance the penetration of drugs into pancreatic tumors. ACS Nano 13, 11008\u201311021 (2019).","journal-title":"ACS Nano"},{"key":"1924_CR31","doi-asserted-by":"publisher","first-page":"6877","DOI":"10.1021\/acs.nanolett.2c01005","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Enhanced intracellular transcytosis of nanoparticles by degrading extracellular matrix for deep tissue radiotherapy of pancreatic adenocarcinoma. Nano Lett. 22, 6877\u20136887 (2022).","journal-title":"Nano Lett."},{"key":"1924_CR32","doi-asserted-by":"publisher","first-page":"17476","DOI":"10.1074\/jbc.M202063200","volume":"277","author":"N Zhou","year":"2002","unstructured":"Zhou, N. et al. Exploring the stereochemistry of CXCR4-peptide recognition and inhibiting HIV-1 entry with d-peptides derived from chemokines. J. Biol. Chem. 277, 17476\u201317485 (2002).","journal-title":"J. Biol. Chem."},{"key":"1924_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/ijabmr.ijabmr_58_23","volume":"13","author":"S Ansari","year":"2023","unstructured":"Ansari, S., Mudassir, M., Vijayalekshmi, B. & Chattopadhyay, P. Targeting CXCR4-expressing cancer cells with avidin-poly (lactic-co-glycolic acid) nanoparticle surface modified with biotinylated DV1 peptide. Int. J. Appl. Basic Med. Res. 13, 106\u2013112 (2023).","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"1924_CR34","doi-asserted-by":"publisher","unstructured":"Houg, D. S. & Bijlsma, M. F. The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma. Mol. Cancer https:\/\/doi.org\/10.1186\/s12943-018-0842-9 (2018).","DOI":"10.1186\/s12943-018-0842-9"},{"key":"1924_CR35","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1053\/j.gastro.2005.06.056","volume":"129","author":"D Saur","year":"2005","unstructured":"Saur, D. et al. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology 129, 1237\u20131250 (2005).","journal-title":"Gastroenterology"},{"key":"1924_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1021\/acsnano.9b03978","volume":"14","author":"Y Xie","year":"2020","unstructured":"Xie, Y. et al. Stromal modulation and treatment of metastatic pancreatic cancer with local intraperitoneal triple miRNA\/siRNA nanotherapy. ACS Nano 14, 255\u2013271 (2020).","journal-title":"ACS Nano"},{"key":"1924_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1023\/A:1015866104055","volume":"8","author":"H Zhao","year":"1991","unstructured":"Zhao, H. & Heindel, N. D. Determination of degree of substitution of formyl groups in polyaldehyde dextran by the hydroxylamine hydrochloride method. Pharm. Res. 8, 400\u2013402 (1991).","journal-title":"Pharm. Res."},{"key":"1924_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2017.03.024","volume":"397","author":"D Qian","year":"2017","unstructured":"Qian, D. et al. Galectin-1-driven upregulation of SDF-1 on pancreatic stellate cells promotes pancreatic cancer metastasis. Cancer Lett. 397, 43\u201351 (2017).","journal-title":"Cancer Lett."},{"key":"1924_CR39","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ijpharm.2011.12.015","volume":"423","author":"M Kato","year":"2012","unstructured":"Kato, M., Hattori, Y., Kubo, M. & Maitani, Y. Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex. Int. J. Pharm. 423, 428\u2013434 (2012).","journal-title":"Int. J. Pharm."},{"key":"1924_CR40","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1128\/iai.7.2.212-217.1973","volume":"7","author":"B Diener","year":"1973","unstructured":"Diener, B., Carrick, L. Jr. & Berk, R. S. In vivo studies with collagenase from Pseudomonas aeruginosa. Infect. Immun. 7, 212\u2013217 (1973).","journal-title":"Infect. Immun."},{"key":"1924_CR41","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.aaa4967","volume":"348","author":"SA Rosenberg","year":"2015","unstructured":"Rosenberg, S. A. & Restifo, N. P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62\u201368 (2015).","journal-title":"Science"},{"key":"1924_CR42","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1158\/1078-0432.CCR-23-3841","volume":"30","author":"M Wehrli","year":"2024","unstructured":"Wehrli, M. et al. Mesothelin CAR T cells secreting anti-FAP\/anti-CD3 molecules efficiently target pancreatic adenocarcinoma and its stroma. Clin. Cancer Res. 30, 1859\u20131877 (2024).","journal-title":"Clin. Cancer Res."},{"key":"1924_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neo.2021.12.005","volume":"24","author":"HH Lee","year":"2022","unstructured":"Lee, H. H. et al. Therapeutic efficacy of T cells expressing chimeric antigen receptor derived from a mesothelin-specific scFv in orthotopic human pancreatic cancer animal models. Neoplasia 24, 98\u2013108 (2022).","journal-title":"Neoplasia"},{"key":"1924_CR44","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1021\/jf60226a042","volume":"27","author":"J Adler-Nissen","year":"1979","unstructured":"Adler-Nissen, J. Determination of the degree of hydrolysis of food protein hydrolysates by trinitrobenzenesulfonic acid. J. Agric. Food Chem. 27, 1256\u20131262 (1979).","journal-title":"J. Agric. Food Chem."}],"container-title":["Nature Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41565-025-01924-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-025-01924-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-025-01924-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T16:11:50Z","timestamp":1757175110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41565-025-01924-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1924"],"URL":"https:\/\/doi.org\/10.1038\/s41565-025-01924-1","relation":{},"ISSN":["1748-3387","1748-3395"],"issn-type":[{"value":"1748-3387","type":"print"},{"value":"1748-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"25 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Z.Z., Q.L. and Y.L. are the inventors of the patents (CN202410362842.5; US18\/619,282) related to this research filed by Shandong University. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}